EARLY RESPONSE PREDICTS SUBSEQUENT RESPONSE TO OLANZAPINE LONG-ACTING INJECTIONS IN THE TREATMENT OF SCHIZOPHRENIA

被引：0
|
作者：
Ascher-Svanum, H. [1 ]
Zhao, F. [1 ]
Nyhuis, A. [1 ]
Lawson, A. H. [1 ]
Stauffer, V. L. [2 ]
Montgomery, W. [3 ]
Witte, M. [2 ]
Detke, H. [1 ]
McDonnell, D. P. [4 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Lilly USA LLC, Indianapolis, IN USA
[3] Eli Lilly & Co, W Ryde, NSW, Australia
[4] Eli Lilly & Co, Cork, Ireland
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)73315-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A553 / A553
页数：1
相关论文
共 50 条
  • [1] Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia
    Haya Ascher-Svanum
    Fangyi Zhao
    Holland C Detke
    Allen W Nyhuis
    Anthony H Lawson
    Virginia L Stauffer
    William Montgomery
    Michael M Witte
    David P McDonnell
    BMC Psychiatry, 11
  • [2] Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia
    Ascher-Svanum, Haya
    Zhao, Fangyi
    Detke, Holland C.
    Nyhuis, Allen W.
    Lawson, Anthony H.
    Stauffer, Virginia L.
    Montgomery, William
    Witte, Michael M.
    McDonnell, David P.
    BMC PSYCHIATRY, 2011, 11
  • [3] A history of antipsychotic long-acting injections in the treatment of schizophrenia
    Crocq, M. -A.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2015, 41 (01): : 84 - 92
  • [4] Response, remission and relapse during the long-term treatment of schizophrenia patients with long-acting injectable risperidone versus olanzapine
    Potapov, A.
    Eduard, T.
    Sergey, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 158 - 158
  • [5] Olanzapine Long-Acting Injection A Review of its Use in the Treatment of Schizophrenia
    Frampton, James E.
    DRUGS, 2010, 70 (17) : 2289 - 2313
  • [6] Efficacy and safety of olanzapine long-acting injection for maintenance treatment of schizophrenia
    Detke, H.
    McDonnell, D.
    Kane, J.
    Naber, D.
    Sethuraman, G.
    Lin, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S393 - S394
  • [7] Olanzapine Long-Acting InjectionA Review of its Use in the Treatment of Schizophrenia
    James E. Frampton
    Drugs, 2010, 70 : 2289 - 2313
  • [8] Patients with schizophrenia prefer long-acting injections
    Hovens, JE
    Roman, B
    Van Dinther, R
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 84 - 84
  • [9] Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
    Di Lorenzo, Rosaria
    Brogli, Alice
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 573 - 581
  • [10] Assessing the infrequent oral supplementation of olanzapine long-acting injection in the treatment of schizophrenia
    Ascher-Svanum, H.
    Peng, X.
    Montgomery, W.
    Faries, D. E.
    Lawson, A. H.
    Witte, M. M.
    Novick, D.
    Jemiai, N.
    Perrin, E.
    McDonnell, D. P.
    EUROPEAN PSYCHIATRY, 2011, 26 (05) : 313 - 319
12345